Author:
Boccardo F.,Rubagotti A.,Amoroso D.,Mesiti M.,Pacini P.,Gallo L.,Sismondi P.,Giai M.,Genta F.,Mustacchi G.,Agostara B.,Bolognesi A.,Villa E.,Schieppati G.,Ausili Cefaro G. P.,Bellantone R.,Farris A.,Sassi M.,Patrone F.
Publisher
Springer Berlin Heidelberg
Reference37 articles.
1. Amoroso D, Boccardo F, Rubagotti A et al (1997a) Adjuvant high dose chemotherapy without bone marrow rescue in breast cancer patients with 10 or more positive nodes: preliminary results of an Italian Breast Cancer Adjuvant Study Group (GROCTA) trial. Breast 6:232
2. Amoroso D, Boccardo F, Rubagotti A et al (1997b) Adjuvant high-dose chemotherapy without bone marrow rescue in breast cancer patients with 10 or more positive nodes: preliminary results of an Italian Breast Cancer Adjuvant Study Group (GROCTA) trial. Proc Am Soc Clin Oncol 16:144
3. Boccardo F, Rubagotti A, Rosso R et al. (1985) Chemotherapy with or without tamoxifen in postmenopausal patients with late breast cancer. A randomized study. J Steroid Biochem 23:1123–1127
4. Boccardo F, Rubagotti A, Bruzzi P et al (1990) Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, estrogen receptor-positive breast cancer patients: results of a multicentric Italian study. J Clin Oncol 8:1310–1320
5. Boccardo F, Rubagotti A, Amoroso D et al (1992) Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen-receptor positive breast cancer patients. An update at 7 years of the 1st GROCTA trial. Eur J Cancer 28:673–680
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献